Microarray Detection of Drug Resistance Genes in Gram-Negative Bacteria
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting drug resistance genes in gram-negative bacteria are limited in accuracy and applicability, particularly for identifying extended-spectrum beta-lactamases (ESBLs) and plasmid-mediated AmpC enzymes, which are crucial for managing antibiotic resistance but often require labor-intensive and costly procedures.
Innovation Solution
Development of kits and microarrays containing specific primer pairs and probes for amplifying and detecting drug resistance genes such as tem, shv, ctx-m-1-type, ctx-m-9-type, mox, cit, dha, acc, ebc, and fox, allowing for PCR amplification and hybridization-based detection on microarrays, enhancing sensitivity and specificity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional detection methods are used for drug resistance genes, then the detection can be performed with simple equipment, but the accuracy and sensitivity of detection are limited
Solution Approach 1:
The detection system is segmented into specialized modules: specific primer pairs for different resistance gene types (tem, shv, ctx-m, ampC), fluorescently labeled probes, and microarray platforms. Each module targets specific gene sequences, enabling accurate detection of multiple resistance mechanisms simultaneously while maintaining manageable system complexity through modular design
Solution Approach 2:
Fluorescently labeled oligonucleotide probes serve as intermediaries between the target DNA sequences and the detection system. These probes hybridize specifically to resistance gene sequences and emit fluorescent signals that can be detected and quantified, thereby translating molecular recognition into measurable signals with high precision
2Adaptability or versatility
If comprehensive detection of multiple resistance genes is performed, then the applicability and coverage increase, but the detection time and operational complexity increase
Solution Approach 1:
Multiple detection capabilities are merged into a single microarray platform that can simultaneously detect various resistance genes (ESBLs, AmpC, carbapenem resistance) using a unified protocol. The microarray contains multiple probe sets that can be hybridized in one experiment, allowing comprehensive resistance profiling in a single detection run rather than requiring separate assays for each gene type
Solution Approach 2:
The detection kit is designed with universal components that can detect multiple types of resistance genes through a common workflow. The same basic protocol, buffer system, and detection methodology apply across different gene targets, making the system versatile and adaptable to various resistance mechanisms without requiring separate specialized procedures for each gene type
3Productivity
If conventional detection procedures are used, then the operational procedures are simpler, but the labor intensity and cost increase
Solution Approach 1:
The system employs self-hybridizing probes where the fluorescently labeled probes automatically bind to their complementary target sequences on the microarray without requiring manual intervention. The detection process is largely automated, with the microarray platform handling probe immobilization, hybridization, and signal detection, thereby reducing labor intensity while maintaining operational simplicity for the user
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The proposed solution enables rapid, accurate, and cost-effective detection of drug resistance genes in gram-negative bacteria, improving the ability to manage antibiotic resistance and guide antibiotic therapy.
Implementation Method 1
a) one or more primer pairs for amplification of a drug resistance gene
Implementation Method 2
b) one or probes for detection of at least one drug resistance gene
Data Source
AI summary
The present invention provides kits and microarrays containing primer pairs for amplifying drug resistance genes and/or probes for detection of drug resistance genes. Also provided are methods of detecting drug resistance genes using kits and microarrays described herein.